BUSINESS SEGMENT INFORMATION (Tables)

9 Months Ended

Jun. 30, 2021

BUSINESS SEGMENT INFORMATION [Abstract]

Segment Reporting Information by Segment

The following table presents selected financial information about the Company’s reportable segments and Corporate for the purpose of reconciling to the consolidated totals for the three and nine months ended June 30, 2021:

For the three months ended June 30, 2021	Consolidated		Global Logistics Services		Manufacturing		Life Sciences		Corporate
Revenue	$	34,826	$	29,369	$	2,073	$	3,384	$	—
Forwarding expenses and cost of revenues		26,058		24,173		944		941		—
Gross profit		8,768		5,196		1,129		2,443		—
Selling, general and administrative		7,158		4,523		682		1,084		869
Amortization of intangible assets		288		—		—		—		288
Operating income (loss)		1,322		673		447		1,359		(1,157	)
Interest expense		141		62		39		34		6
Identifiable assets		72,494		26,903		3,644		10,366		31,581
Capital expenditures		47		33		—		14		—

For the nine months ended June 30, 2021	Consolidated		Global Logistics Services		Manufacturing		Life Sciences		Corporate
Revenue	$	91,446	$	76,002	$	6,471	$	8,973	$	—
Forwarding expenses and cost of revenues		68,680		62,818		2,985		2,877		—
Gross profit		22,766		13,184		3,486		6,096		—
Selling, general and administrative		19,282		11,640		2,007		3,273		2,362
Amortization of intangible assets		832		—		—		—		832
Operating income (loss)		2,652		1,544		1,479		2,823		(3,194	)
Interest expense		418		180		129		89		20
Identifiable assets		72,494		26,903		3,644		10,366		31,581
Capital expenditures		218		76		15		127		—

The following table presents selected financial information about the Company’s reportable segments and Corporate for the purpose of reconciling to the consolidated totals for the three and nine months ended June 30, 2020:

For the three months ended June 30, 2020	Consolidated			Global Logistics Services			Manufacturing		Life Sciences		Corporate
Revenue	$	18,498		$	15,565		$	1,605	$	1,328	$	—
Forwarding expenses and cost of revenues		13,405			12,194			752		459		—
Gross profit		5,093			3,371			853		869		—
Selling, general and administrative		5,482			3,429			482		951		620
Amortization of intangible assets		243			—			—		—		243
Operating (loss) income		(632	)		(58	)		371		(82)		(863	)
Interest expense		108			30			49		25		4
Identifiable assets		51,794			13,173			2,472		9,776		26,373
Capital expenditures		157			28			11		118		—

For the nine months ended June 30, 2020	Consolidated			Global Logistics Services		Manufacturing		Life Sciences		Corporate
Revenue	$	57,440		$	46,972	$	5,531	$	4,937	$	—
Forwarding expenses and cost of revenues		40,064			35,896		2,505		1,663		—
Gross profit		17,376			11,076		3,026		3,274		—
Selling, general and administrative		18,151			11,019		1,865		3,002		2,265
Amortization of intangible assets		729			—		—		—		729
Operating (loss) income		(1,504	)		57		1,161		272		(2,994	)
Interest expense		412			150		187		76		(1	)
Identifiable assets		51,794			13,173		2,472		9,776		26,373
Capital expenditures		288			92		34		162		—